Treatment of Subclinical Hyperthyroidism

Place de l'Iode RadioActif Dans l'HyperThyroïdiE Sub-clinique (PIRHATES)/ Evaluation of the Interest of Subclinical Hyperthyroidism Treatment

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00213720

Enrollment

145

Registered

2005-09-21

Start date

2005-08-31

Completion date

2020-01-31

Last updated

2020-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Subclinical Hyperthyroidism

Keywords

Hyperthyroidism, atrial fibrillation, quality of life, radioiodine treatment

Brief summary

Objective: To determine if the treatment of subclinical hyperthyroidism will reduce the rate of atrial fibrillation, the main complication of this condition.

Detailed description

Randomized open-labelled multicentre study comparing radioiodine vs medical supervision without treatment

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

50 Years to No maximum

Healthy volunteers

Inclusion criteria

* Men and women aged 50 and greater * Isolated decreased thyroid-stimulating hormone (TSH) with normal FT4 and FT3 levels

Exclusion criteria

* Iodide overload * Non sinusal heart rhythm * Severe heart disease

Countries

France

Outcome results